Premarket Decliner
GRI Gri Bio2.05+0.09+4.6%
Premarket:1.53-0.52 (-25.4%)
GRI Bio Reports 6-Week Interim Biomarker Data in Ongoing Phase 2a Study in Idiopathic Pulmonary Fibrosis ("IPF")
Globe NewswireThu, 31-Jul 9:00 AM
